Literature DB >> 26709764

Molecular mechanisms in differentiated thyroid cancer.

Jing Xie1, Youben Fan2, Xiaoping Zhang3.   

Abstract

Thyroid cancer is a common endocrine malignancy. The tumorigenesis of thyroid tumours has been identified in recent years, including numerous genetic alterations and several major signalling pathways. However, the molecular mechanisms involved in thyroid cancer metastasis remain controversial. Studies in thyroid cancer metastasis suggested that reactivation of several pathways, including epithelial to mesenchymal transition and microenvironment change, may be involved in thyroid cancer migration. The previously identified thyroid oncogenes, BRAF, RET/PTC and Ras, play important roles in regulating the metastatic process. Here, we review the recent knowledge eon molecular mechanisms involved in thyroid cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26709764     DOI: 10.2741/4379

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  10 in total

1.  Intramedullary Spinal Cord Metastases from Differentiated Thyroid Cancer, a Case Report.

Authors:  Fabio Volpe; Leandra Piscopo; Mariarosaria Manganelli; Maria Falzarano; Federica Volpicelli; Carmela Nappi; Massimo Imbriaco; Alberto Cuocolo; Michele Klain
Journal:  Life (Basel)       Date:  2022-06-09

2.  miR-3619-3p promotes papillary thyroid carcinoma progression via Wnt/β-catenin pathway.

Authors:  Shuang Yu; Siting Cao; Shubin Hong; Xiaorong Lin; Hongyu Guan; Shuwei Chen; Quan Zhang; Weiming Lv; Yanbing Li; Haipeng Xiao
Journal:  Ann Transl Med       Date:  2019-11

3.  Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.

Authors:  Shengqing Hu; Yunfei Liao; Lulu Chen
Journal:  Med Sci Monit       Date:  2018-09-14

4.  Association of rs944289, rs965513, and rs1443434 in TITF1/TITF2 with Risks of Papillary Thyroid Carcinoma and with Nodular Goiter in Northern Chinese Han Populations.

Authors:  Xin Zhang; Yulu Gu; Yong Li; Heran Cui; Xiaoli Liu; Hui Sun; Qiong Yu; Yaqin Yu; Yawen Liu; Siyan Zhan; Yi Cheng
Journal:  Int J Endocrinol       Date:  2020-02-11       Impact factor: 3.257

5.  Overexpression of novel long intergenic non‑coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer.

Authors:  Juan Tan; Ling Liu; Zhihua Zuo; Bin Song; Tingting Cai; Dafa Ding; Yibing Lu; Xiaolong Ye
Journal:  Oncol Rep       Date:  2020-08-03       Impact factor: 3.906

6.  Silencing of A-Kinase Anchor Protein 4 (AKAP4) Inhibits Proliferation and Progression of Thyroid Cancer.

Authors:  Jiakai Han; Wei Gao; Dongyue Su; Yang Liu
Journal:  Oncol Res       Date:  2016-11-08       Impact factor: 5.574

7.  The direct miR-874-3p-target FAM84A promotes tumor development in papillary thyroid cancer.

Authors:  Yu Ding; Luyao Wu; Xi Zhuang; Jingsheng Cai; Houchao Tong; Yan Si; Hao Zhang; Xiaoting Wang; Meiping Shen
Journal:  Mol Oncol       Date:  2021-03-23       Impact factor: 6.603

8.  Diffusion-Weighted Imaging Using a Readout-Segmented, Multishot EPI Sequence at 3 T Distinguishes between Morphologically Differentiated and Undifferentiated Subtypes of Thyroid Carcinoma-A Preliminary Study.

Authors:  Stefan Schob; Peter Voigt; Lionel Bure; Hans-Jonas Meyer; Claudia Wickenhauser; Curd Behrmann; Annekathrin Höhn; Paul Kachel; Henning Dralle; Karl-Titus Hoffmann; Alexey Surov
Journal:  Transl Oncol       Date:  2016-09-20       Impact factor: 4.243

9.  miR-873-5p Inhibits Cell Migration and Invasion of Papillary Thyroid Cancer via Regulation of CXCL16.

Authors:  Zhenglin Wang; Wei Liu; Cong Wang; Zhilong Ai
Journal:  Onco Targets Ther       Date:  2020-02-04       Impact factor: 4.147

10.  GPX7 promotes the growth of human papillary thyroid carcinoma via enhancement of cell proliferation and inhibition of cell apoptosis.

Authors:  Li-Dan Liu; Yi-Ni Zhang; Li-Fen Wang
Journal:  Transl Cancer Res       Date:  2019-11       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.